Koers Shenzhen Bioeasy Biotechnology Co., Ltd.
Aandelen
300942
CNE100004C78
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,8 CNY | +1,19% | +0,74% | -41,83% |
Omzet 2021 | 598 mln. 82,46 mln. 76,91 mln. | Omzet 2022 | 687 mln. 94,79 mln. 88,41 mln. | Marktkapitalisatie | 6,87 mld. 948 mln. 884 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 237 mln. 32,71 mln. 30,5 mln. | Nettowinst (verlies) 2022 | 83 mln. 11,45 mln. 10,68 mln. | EV/omzet 2021 | 18,3 x |
Nettoliquiditeiten 2021 | 641 mln. 88,5 mln. 82,54 mln. | Nettoliquiditeiten 2022 | 310 mln. 42,78 mln. 39,9 mln. | EV/omzet 2022 | 9,55 x |
K/w-verhouding 2021 |
48,1
x | K/w-verhouding 2022 |
81,6
x | Werknemers | 635 |
Dividendrendement 2021 |
0,86% | Dividendrendement 2022 |
0,12% | Vrij verhandelbaar | 22,42% |
1 dag | +1,19% | ||
1 week | +0,74% | ||
Lopende maand | -22,46% | ||
1 maand | -17,68% | ||
3 maanden | -31,66% | ||
6 maanden | -41,18% | ||
Lopend jaar | -41,83% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Zhao Li Xiao
CEO | Chief Executive Officer | 50 | 29-07-22 |
Kai Wan
DFI | Director of Finance/CFO | 42 | 27-12-21 |
Mei Xia Li
CHM | Chairman | 36 | 01-06-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hui Fu
BRD | Director/Board Member | 40 | 01-03-08 |
Xi Li Wang
BRD | Director/Board Member | 39 | 01-07-10 |
Mei Xia Li
CHM | Chairman | 36 | 01-06-12 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 6,8 | +1,19% | 3 805 265 |
23-04-24 | 6,72 | +6,33% | 6 542 223 |
22-04-24 | 6,32 | -2,02% | 5 695 954 |
19-04-24 | 6,45 | -1,98% | 4 209 758 |
18-04-24 | 6,58 | -2,52% | 5 622 400 |
slotkoers Shenzhen S.E., 24 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-41,83% | 376 mln. | |
-11,57% | 7,5 mld. | |
+2,10% | 5,48 mld. | |
+0,98% | 4,61 mld. | |
+5,18% | 4,47 mld. | |
-50,82% | 3,28 mld. | |
+11,23% | 2,71 mld. | |
-14,95% | 2,02 mld. | |
-2,66% | 1,69 mld. | |
-10,84% | 1,74 mld. |